Sun Pharma reported consolidated revenue growth of 18.6% for Q2 FY27, led by its Film Making division, which contributed 31.4% of the total. Operating margin held at 5.5%, a few basis points below the previous quarter as higher logistics and wage costs offset operating leverage.
Environmental, social and governance targets also featured. The company reiterated its goal to reduce emissions intensity by a third by 2030, and disclosed that 31.4% of electricity at its main sites now comes from renewable sources under long-term contracts.
The numbers
Employees and communities are part of the plan: a skills academy near the new site will train 2,000 technicians over three years, funded jointly with the state government. Management said local hiring is a condition of the incentives it has received.
Analysts were broadly constructive. Of 18 brokerages covering the stock, 12 maintain buy ratings, with target prices implying about 31.4% upside. The more cautious voices pointed to a valuation premium and the execution risk inherent in a large expansion programme.
By the numbers
Balance-sheet metrics remain comfortable. Net debt to earnings stood at 0.8 times, and the company retired $245 million of high-cost borrowings during the quarter. Credit analysts say the improvement leaves room to fund the expansion without equity dilution.
“We are building where the customers are asking us to build. That is the simplest capital-allocation rule there is.”
Expansion and capital allocation
Capital expenditure guidance was raised to $5.1 billion for the fiscal year, from $245 million previously. Management said the increase reflects accelerated spending on automation and on debottlenecking existing lines, which it expects to deliver 5.5% more output without additional land.
Source: IGEN Intelligence analysis of directorate general of foreign trade data. Illustrative mock data.
The company also announced a new facility near Hazira, designed to add about 2,210 tonnes of annual capacity and create roughly 1,200 jobs. Construction begins next quarter, and first production is targeted within 20 months. The plant will be built to meet European environmental standards.
| Segment | Revenue | YoY | Margin |
|---|---|---|---|
| Film Making (core) | $224M | +4% | 11.8% |
| Exports | $42M | +13.2% | 14.8% |
| Domestic retail | $283M | -1.3% | 11.3% |
| Services | $516M | +18% | 8.6% |
| Other | $346M | +1.5% | 22.6% |
Customers, contracts and exports
On the post-results call, management said the order book now stands at $5.1 billion, equivalent to roughly 14 months of revenue, with about a third from export customers in Australia and South Korea. The chief financial officer described visibility as the best in five years.
Timeline of key events
- Results announced
Revenue up 18.6%; margin steady at 5.5%.
- Capex raised
Guidance moves to $5.1 billion to fund automation and debottlenecking.
- Supply pact signed
Multi-year agreement with Havells India at index-linked pricing.
- Groundbreaking
Construction at the new facility near Hazira begins.
- First production
Targeted within 20 months of groundbreaking.
Export performance was a bright spot. Shipments to Australia rose 18.6%, helped by certification wins and shorter lead times from Hazira. Management said it would deepen its presence in the market by adding a local warehouse and a technical service team.
Expert commentary
“The pact is not just volume; it is a joint roadmap for higher-value products.”
“Buyers are paying a premium for certainty. Suppliers who can document, deliver and communicate will capture it.”
“In my conversations with procurement heads, reliability is mentioned three times for every mention of price.”
Risks and analyst view
Risks were not ignored. Executives flagged input-cost volatility, potential delays in environmental clearances for the new plant and the possibility of tougher competition from lower-priced imports. They said a pricing-pass-through mechanism covers about 60 percent of exposure.
What it means for you
Order visibility and a manageable balance sheet support the story; track execution on the new plant and margin pass-through.
Expansion will lift procurement; engage early on qualification for the new lines.
Longer-term agreements offer price stability in exchange for volume commitments; compare index-linked terms carefully.
About 1,200 direct roles and a technician academy are planned near Hazira; applications open with the state skills portal.
Companies and leaders in this story
Frequently asked questions
Sources
- Directorate General of Foreign Trade: Export-import policy and public notices
- Port authority statistics: Container volumes, dwell times and berth productivity
- Central Board of Indirect Taxes & Customs: Port-level clearance and dwell data
- Reserve Bank of India: Exchange-rate and trade-credit bulletins
Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.
